Isovaleryl-CoA dehydrogenase

From WikiMD's WELLNESSPEDIA

Isovaleryl-CoA dehydrogenase is an enzyme that plays a crucial role in the metabolism of branched-chain amino acids, specifically leucine. It is a member of the acyl-CoA dehydrogenase family, which is involved in the beta-oxidation of fatty acids.

Function[edit]

Isovaleryl-CoA dehydrogenase catalyzes the third step in the breakdown of leucine, converting isovaleryl-CoA to 3-methylcrotonyl-CoA. This reaction involves the removal of electrons from isovaleryl-CoA, which are transferred to the electron transfer flavoprotein (ETF), ultimately contributing to the electron transport chain and ATP production.

Structure[edit]

The enzyme is a homotetramer, meaning it consists of four identical subunits. Each subunit contains a flavin adenine dinucleotide (FAD) cofactor, which is essential for its dehydrogenase activity. The structure of isovaleryl-CoA dehydrogenase has been elucidated through X-ray crystallography, revealing details about its active site and substrate binding.

Clinical significance[edit]

Deficiency in isovaleryl-CoA dehydrogenase activity leads to a metabolic disorder known as isovaleric acidemia. This condition is characterized by the accumulation of isovaleric acid, which can cause severe metabolic acidosis, a distinctive "sweaty feet" odor, and neurological complications. Early diagnosis and management are crucial to prevent serious outcomes.

Related enzymes[edit]

Isovaleryl-CoA dehydrogenase is part of a larger family of acyl-CoA dehydrogenases, which includes:

Related pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.